Alerts will be sent to your verified email
Verify Email
NOVARTIND
|
Novartis
|
Clean Science
|
Granules India
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceutical Sector
|
|||
|
Domestic Sales Growth - YoY
|
-5.28 % | n/a | n/a |
|
Financials
|
|||
|
5 yr Average ROE
|
4.79 % | 33.24 % | 18.62 % |
|
5yr average Equity Multiplier
|
2.61 | 1.2 | 1.78 |
|
5yr Average Asset Turnover Ratio
|
0.23 | 0.79 | 0.84 |
|
5yr Avg Net Profit Margin
|
8.94 % | 35.06 % | 12.53 % |
|
Price to Book
|
3.65 | 13.23 | 3.76 |
|
P/E
|
31.89 | 65.25 | 29.91 |
|
5yr Avg Cash Conversion Cycle
|
-42.92 Days | -5.39 Days | 49.48 Days |
|
Inventory Days
|
40.74 Days | 34.78 Days | 66.04 Days |
|
Days Receivable
|
32.03 Days | 58.46 Days | 75.78 Days |
|
Days Payable
|
113.51 Days | 106.38 Days | 105.66 Days |
|
5yr Average Interest Coverage Ratio
|
26.75 | 678.73 | 19.25 |
|
5yr Avg ROCE
|
4.35 % | 43.07 % | 21.19 % |
|
5yr Avg Operating Profit Margin
|
18.55 % | 50.41 % | 21.42 % |
|
5 yr average Debt to Equity
|
0.0 | 0.0 | 0.46 |
|
5yr CAGR Net Profit
|
14.83 % | 16.15 % | 16.92 % |
|
5yr Average Return on Assets
|
1.84 % | 27.66 % | 10.57 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
70.68 % | 74.98 % | 41.96 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 4.03 % |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -19.67 % | -0.08 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 3.85 % | 5.8 % |
|
Novartis
|
Clean Science
|
Granules India
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|